Clin2
NCT07843927Possibly a fitRecruiting

Adding DHEA hormone to antidepressants for difficult depression

Treatment Resistant Depression (TRD)

Part of Mental health clinical trials.

This study tests whether adding a natural hormone called DHEA to your regular antidepressant can help improve depression symptoms. DHEA is a supplement that may boost the effectiveness of standard antidepressants for people with hard-to-treat depression.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
320 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are between 18 and 75 years old.
  • You have been diagnosed with major depression that hasn't responded to at least one antidepressant treatment.
  • Your depression severity score is at least 20 on a standard scale.
  • You are currently taking a standard antidepressant at a stable dose for at least 4 weeks.
  • You have not tried more than three different antidepressants for the current episode.
  • You are not taking certain other psychiatric medications (like antipsychotics or lithium).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07210112Recruiting· Phase 2
Psilocybin and Trazodone for tough-to-treat depression

This trial tests if taking psilocybin (a psychedelic drug) with trazodone (an antidepressant) can help people whose depression hasn't improved with at least two standard antidepressants. If you have treatment-resistant depression, this study might be an option.

Paris
NCT07543328Recruiting
Light therapy added to antidepressants for depression with body symptoms

This study tests whether a special light treatment applied to the scalp (transcranial photobiomodulation) can help people with depression who aren't getting better with antidepressants alone. The light therapy is added to your current medication to see if it reduces both mood symptoms and physical complaints like pain or fatigue.

Taipei
NCT07369102Recruiting· Phase 4
Esketamine with or without talk therapy for tough depression

This trial tests if adding a type of talk therapy called integration therapy helps esketamine work better for people with depression that hasn't improved with other treatments. You'll receive esketamine, and some people also get guided sessions to reflect on their experiences.

San Juan
NCT06967857Recruiting· Phase 2
Dexamfetamine for adults with ADHD and depression

This trial tests a study medication (dexamfetamine) for adults who have both ADHD and moderate to severe depression. It aims to see if the medication is safe and helps improve both conditions.

Berlin
NCT07610473Recruiting· Phase 2
Testing DT-101 as an add-on for depression

This trial tests if a new medication, DT-101, can help when added to your current depression treatment. It's for adults with recurrent depression who may need extra support.

Phoenix, Arizona
NCT06958692Recruiting· Phase 3
Testing a new antidepressant combination for depression

This study tests a new combination of two medications (dextromethorphan and bupropion) as a treatment for major depressive disorder. It may be an option if you have not already tried many antidepressants that didn't work.

Beijing, Beijing Municipality

Hear when a new Treatment Resistant Depression (TRD) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.